Startseite Crystal structure of N-(2-methylphenyl)(propan-2-yloxy)carbothioamide, C11H15NOS
Artikel Open Access

Crystal structure of N-(2-methylphenyl)(propan-2-yloxy)carbothioamide, C11H15NOS

  • Chien Ing Yeo und Edward R.T. Tiekink EMAIL logo
Veröffentlicht/Copyright: 22. Februar 2019

Abstract

C11H15NOS, monoclinic, P21/n (no. 14), a = 7.3979(4) Å, b = 8.5384(4) Å, c = 18.2771(10) Å, β = 90.999(3)°, V = 1154.32(10) Å3, Z = 4, Rgt(F) = 0.0409, wRref(F2) = 0.1093, T = 100(2) K.

CCDC no.: 1895047

The title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.27 × 0.11 × 0.11 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.25 mm−1
Diffractometer, scan mode:Bruker SMART APEX, ω
θmax, completeness:27.5°, >99%
N(hkl)measured, N(hkl)unique, Rint:10515, 2649, 0.058
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2186
N(param)refined:133
Programs:Bruker [1], SHELX [2], [3], [4], WinGX/ORTEP [5]

Source of material

All chemicals and solvents were used as purchased without purification. All reactions were carried out under ambient conditions. The melting point was determined on a Krüss KSP1N melting point meter. The IR spectrum was obtained on a Perkin Elmer Spectrum 400 FT Mid-IR/Far-IR spectrophotometer from 4000 to 400 cm−1; abbreviation: s, strong. Elemental analyses were performed on a Perkin Elmer PE 2400 CHN Elemental Analyser.

Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
S10.31646(5)0.92776(5)1.08505(2)0.02241(14)
O10.08168(14)0.74832(13)1.00997(6)0.0207(3)
N10.30848(17)0.84343(16)0.94626(7)0.0204(3)
H1N0.4082(17)0.8953(19)0.9436(10)0.025*
C10.23022(19)0.83559(18)1.01114(8)0.0184(3)
C20.2401(2)0.78416(18)0.87761(8)0.0183(3)
C30.3557(2)0.69622(19)0.83442(9)0.0233(4)
C40.2909(3)0.6479(2)0.76591(10)0.0311(4)
H40.36790.58930.73510.037*
C50.1177(3)0.6831(2)0.74184(9)0.0340(4)
H50.07670.64910.69490.041*
C60.0044(2)0.7679(2)0.78616(10)0.0312(4)
H6−0.11540.79090.77000.037*
C70.0651(2)0.81951(19)0.85417(9)0.0228(3)
H7−0.01230.87870.88450.027*
C80.5424(2)0.6509(2)0.86049(11)0.0352(4)
H8A0.59970.58550.82340.053*
H8B0.53430.59220.90640.053*
H8C0.61490.74560.86870.053*
C9−0.0271(2)0.73030(19)1.07634(8)0.0209(3)
H9−0.02880.83131.10400.025*
C100.0529(2)0.6032(2)1.12380(10)0.0303(4)
H10A0.17740.63101.13770.045*
H10B0.05270.50421.09670.045*
H10C−0.01920.59161.16800.045*
C11−0.2154(2)0.6921(2)1.04822(10)0.0287(4)
H11A−0.25810.77621.01580.043*
H11B−0.29700.68211.08960.043*
H11C−0.21290.59321.02100.043*

o-Tolyl isothiocyanate (Sigma Aldrich; 2.5 mmol, 0.33 mL) was added to NaOH (Merck; 2.5 mmol, 0.10 g) in iPrOH (Merck; 5 mL) and the mixture was left stirring at room temperature for 2 h, followed by the addition of excess 5 M HCl solution. The resulting mixture was stirred for another 1.5 h. The final product was extracted with chloroform (Merck; 20 mL) and left for evaporation at room temperature, yielding colourless crystal after 4 weeks. M.pt: 323−324 K. IR (cm−1): 3208 (s) ν(N—H), 1459 (s) ν(C—N), 1204 (s) (C= S), 1094 (s) ν(C—O). Anal. Calc. for C11H15NOS: C, 63.12; H, 7.22; N, 6.69%. Found: C, 63.15; H, 7.42; N, 6.92%.

Experimental details

The C-bound H atoms were geometrically placed (C—H = 0.95−1.00 Å) and refined as riding with Uiso(H) = 1.2−1.5Ueq(C). The N-bound H-atom was located in a difference Fourier map but refined with a distance restraint of N—H = 0.88 ±0.01 Å, and with Uiso(H) set to 1.2Uequiv(N).

Comment

The title compound was investigated as part of continuing and systematic crystal chemical studies of alkoxycarbothioamides [6], [7], [8], [9], i.e. molecules of the general formula ROC(=S)N(H)R′ (R/R′ = alkyl and/or aryl). Continued synthesis of these molecules is also motivated by the exciting biological activity exhibited by their phosphanegold(I) derivatives, e.g. as anti-microbial [10] and anti-cancer [11] agents, and the observed dependence of biological potential upon the nature of R and R′. In the present communication, the crystal and molecular structures of the title compound, iPrOC(=S)N(H)C6H4Me-2, are described.

The molecular structure is shown in the figure (70% displacement ellipsoids) and features the normally observed [6], [7], [8], [9] syn-disposition of the thione-S and thioamide-N—H atoms. The central residue is strictly planar with the [r.m.s. deviation of the S1, O1, N1, C1 atoms = 0.0011 Å] and forms a dihedral angle of 53.63(4)° with the appended 2-tolyl group. The key geometric parameters are C1 = S1 = 1.6796(15) Å, C1—O1 = 1.3275(18) Å, C1—N1 = 1.330(2) Å, S1—C1—O1 = 125.35(11)°, S1—C1—N1 = 121.88(12)° and O1—C1—N1 = 112.77(13)°. These follow the expected trends [6], [7], [8], [9].

The molecular packing features thioamide-N—H⋯S(thione) hydrogen bonds [N1–H1n⋯S1i: H1n⋯S1i = 2.597(14) Å, N1⋯S.i = 3.4494(14) Å with angle at H1n = 170.0(15)° for symmetry operation (i) 1 − x, 2 − y, 2 − z] between centrosymmetrically related molecules to generate an eight-membered {⋯HNCS}2 synthon. Globally, the dimeric aggregates thus formed stack in columns along the a-axis. The connections between the columns leading to a three-dimensional architecture are of the type tolyl-C—H⋯S(thione) [C5–H5⋯S1ii: H5⋯S1ii = 2.83 Å, C5⋯S1ii = 3.7218(19) Å with angle at H5 = 156°; C7—H7⋯S1iii: H7⋯S1iii = 2.85 Å, C7⋯S1iii = 3.7374(16) Å with angle at H7 = 155°, for symmetry operations: (ii) -1/2 + x, 3/2 − y, -1/2 + z; (iii) − x, 2 − y, 2 − z].

The present structure determination completes the series of structures of general formula ROC(=S)N(H)C6H4Me-2, i.e. for R = Me [12] and Et [13]. While not isostructural, the three structures exhibit the same trends in geometric parameters and in their respective crystals, the formation of eight-membered {⋯HNCS}2 synthons mediated by thioamide-NH⋯S(thione) hydrogen bonds.

Acknowledgements

The University of Malaya’s X-ray laboratory is thanked for the data collection. Sunway University is thanked for support of crystal engineering and biological studies of thiocarbamides and their metal complexes.

References

1. Bruker. APEX2 and SAINT. Bruker AXS Inc., Madison, WI, USA (2008).Suche in Google Scholar

2. Sheldrick, G. M.: SADABS. University of Göttingen, Germany (1996).Suche in Google Scholar

3. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

4. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar PubMed PubMed Central

5. Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Cryst. 45 (2012) 849–854.10.1107/S0021889812029111Suche in Google Scholar

6. Ho, S. Y.; Bettens, R. P. A.; Dakternieks, D.; Duthie, A.; Tiekink, E. R. T.: Prevalence of the thioamide (⋯H—N—C=S)2 synthon solid-state (X-ray crystallography), solution (NMR) and gas-phase (theoretical) structures of O-methyl-N-aryl-thiocarbamides. CrystEngComm 7 (2005) 682–689.10.1039/b514254gSuche in Google Scholar

7. Kuan, F. S.; Mohr, F.; Tadbuppa, P. P.; Tiekink, E. R. T.: Principles of crystal packing in O-isopropyl-Naryl- thiocarbamides: iPrOC(=S)N(H)C6H4-4-Y: Y = H, Cl, and Me. CrystEngComm 9 (2007) 574–581.10.1039/B701489ASuche in Google Scholar

8. Ellis, C. A.; Miller, M. A.; Spencer, J.; Zukerman-Schpector, J.; Tiekink, E. R. T.: Co-crystallization experiments of thiocarbamides with bipyridine-type molecules. CrystEngComm 11 (2009) 1352–1361.10.1039/b822555aSuche in Google Scholar

9. Jotani, M. M.; Yeo, C. I.; Tiekink, E. R. T.: A new monoclinic polymorph of N-(3-methylphenyl) ethoxycarbothioamide: crystal structure and Hirshfeld surface analysis. Acta Crystallogr. E73 (2017) 1889–1897.10.1107/S2056989017016280Suche in Google Scholar PubMed PubMed Central

10. Yeo, C. I.; Sim, J.-H.; Khoo, C.-H.; Goh, Z.-J.; Ang, K.-P.; Cheah, Y.-K.; Fairuz, Z. A.; Halim, S. N. B. A.; Ng, S. W.; Seng, H.-L.; Tiekink, E. R. T.: Pathogenic Gram-positive bacteria are highly sensitive to triphenylphosphanegold(O-alkylthiocarbamates), Ph3PAu[SC(OR)=N(p-tolyl)] (R = Me, Et and iPr). Gold Bull. 46 (2013) 145–152.10.1007/s13404-013-0091-zSuche in Google Scholar

11. Ooi, K. K.; Yeo, C. I.; Mahandaran, T.; Ang, K. P.; Akim, A. M.; Cheah, Y.-K.; Seng, H.-L.; Tiekink, E. R. T.: G2/M cell cycle arrest on HT-29 cancer cells and toxicity assessment of triphenylphosphanegold(I) carbonimidothioates, Ph3PAu[SC(OR)=NPh], R = Me, Et, and iPr, during zebrafish development. J. Inorg. Biochem. 166 (2017) 173–181.10.1016/j.jinorgbio.2016.11.008Suche in Google Scholar PubMed

12. Kuan, F. S.; Tadbuppa, P.; Tiekink, E. R. T.: Crystal structure of o-methyl N-(o-tolyl)thiocarbamate, SC(OCH3)NH(C6H4CH3). Z. Kristallogr. NCS 220 (2005) 393–394.10.1524/ncrs.2005.220.14.413Suche in Google Scholar

13. Yeo, C. I.; Tiekink, E. R. T.: Crystal structure of N-(2-methylphenyl)ethoxycarbothioamide, C10H13NOS. Z. Kristallogr. NCS 233 (2018) 299–301.10.1515/ncrs-2017-0295Suche in Google Scholar

Received: 2019-01-14
Accepted: 2019-02-01
Published Online: 2019-02-22
Published in Print: 2019-03-26

©2019 Chien Ing Yeo et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of poly[aqua-μ2-4,4′-bis(pyrid-4-yl)biphenyl-κ2N:N′)-μ4-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-κ4O:O′:O′′:O′′′)manganese(II)], C52H40N2O10Mn2
  3. Crystal structure of bis[2-(((3-aminopropyl)imino)methyl)-4-nitro-phenolato-κ3N,N′,O]nickel(II), C20H24N6NiO6
  4. Synthesis and crystal structure of bis{2-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl) phenolato-κ2N,O}cobalt(II) — ethanol (1/1), C34H36CoN4O5
  5. Crystal structure of 1-(4-{2,5-dichloro-3-hydroxy-4-[4-(1-methoxyimino-ethyl)-phenylamino]-6-methyl-phenylamino}-phenyl)-ethanone O-methyl-oxime, C24H22Cl2N4O4
  6. The pseudosymmetric crystal structure of 2,4,6,8,10,12-hexanitrohexaazaisowurtzitane dimethyl carbonate (2/3), C21H30N24O33
  7. Crystal structure of (1,4-diazepane)4CuII2(μ-Cl)10CuI6, C20H48Cl10Cu8N8
  8. Crystal structure of methyl 2,7,7-trimethyl-4-(3-methylthiophen-2-yl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C19H23NO3S
  9. Crystal structure of methyl 2-(4-(pyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C15H13N3O2
  10. Crystal structure of (1S,3aR,3bR,10aR,10bR,12aR)-8-amino-3a,3b,6,6,10a-pentamethyl-1-((S)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)-2,3,3a,3b,4,5,5a,6,10,10a,10b,11,12,12a-tetradecahydro-1H-cyclopenta[7,8]phenanthro[2,3-d]thiazol-12-ol – a panaxadiol dervative, C31H50N2O2S
  11. Crystal structure of bis[(((4-fluorophenyl)amino)methyl)triphenylphosphonium] tetrachloridocobaltate(II), C50H44Cl4CoF2N2P2
  12. Crystal structure of 5,4′-dihydroxy-7,3′-dimethoxyflavanone, C17H16O6
  13. Crystal structure of 3-methyl-cyclobis(1-(1,1′-ferrocenylmethyl)-4-butyl-1H-1,2,3-triazole) tetrafluoroborate, C21H25FeN6⋅BF4
  14. Crystal structure of 3-(2-diethylaminoethyl)-2,3-dihydro-2-thioxoquinazolin-4(1H)-one, C14H19N3OS
  15. Crystal structure of 2-(bis(3,5-dimethylphenyl) ((methyldiphenylsilyl)oxy)methyl) pyrrolidine, C34H39NOSi
  16. The crystal structure of 1,4-dinitro-2,3,5,6-tetraacetoxy-piperazine, C12H16N4O12
  17. Crystal structure of rac-3,6-dimethyl-5-(prop-1-en-2-yl)-6-vinyl-1,4,5,6-tetrahydro-2H-indol-2-one, C15H19NO
  18. Crystal structure of (Cu0.51In0.49)tet[Cr1.74In0.26]octSe4 selenospinel, Cu0.51In0.75Cr1.74Se4
  19. Crystal structure of 7-hydroxy-5-methoxy-4,6-dimethylisobenzofuran-1(3H)-one, C11H12O4
  20. Crystal structure of trans-tetrakis(acetonitrile-κN)bis(triphenylphosphine-κP)ruthenium(II) dihexafluorophosphate - dichloroform (1/2), C46H44Cl6F12N4P4Ru
  21. Crystal structure of 2-((4-nitrophenyl)thio)ethan-1-ol, C8H9NO3S
  22. Crystal structure of diaqua-dichlorido-bis(μ3-6,6′-(hydrazine-1,2-diylidenebis(methanylylidene))bis(2-methoxyphenolato)κ6O,N:N′,O′,O′:O′′)trizinc(II) - ethanol (1/2), C36H44Cl2N4O12Zn3
  23. Crystal structure of the co-crystal 2-[(2-carboxyphenyl)disulfanyl]benzoic acid – 3-chlorobenzoic acid (2/1), C35H25ClO10S4
  24. The crystal structure of 4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol, C15H11ClFN3O2
  25. Crystal structure of ethyl (E)-1-(3-ethoxy-3-oxoprop-1-en-1-yl)-2-(4-nitrophenyl)-2,5-dihydro-1H-benzo[b][1,4]diazepine-3-carboxylate, C23H23N3O6
  26. Crystal structure of (E)-2-(4-cyanophenyl)ethenesulfonyl fluoride, C9H6FNO2S
  27. Crystal structure of bis(4-bromo-2-(((3-chloropropyl)imino)methyl)phenolato-κ2N,O)-oxidovanadium(IV), C20H20Br2Cl2N2O3V
  28. The crystal structure of 1,1,1,3,3,3-hexaphenyldistannoxane – 2,2′-bipyridine (1/1), C46H38N2OSn2
  29. Crystal structure of coordination polymer catena-poly[diaqua-(2,6-dichloropyridine-4-carboxyliato-κ2O,O′)-bis(μ2-2,6-dichloropyridine-4-carboxyliato-κ2O:O′)terbium(III), C18H10Cl6N3O8Tb
  30. The crystal structure of 4-((2-(4,5-dihydro-1,5-diphenyl-1H-pyrazol-3-yl)anthracen-10-yl) methyl)morpholine, C34H31N3O
  31. The crystal structure of bis(N,N-dimethylformamide-κO)-tetrakis(9H-xanthene-9-carboxylic-carboxylate-κ2O:O′)dicopper(II) - acetonitrile (1/2), C66H56Cu2N4O14
  32. Crystal structure of trans-dichlorido-(1,3-dimesityl-1H-imidazol-2(3H)-ylidene)-(5-methyl-3,4-dihydro-2H-pyrrole-κN)palladium(II), C25H31Cl2N3OPd
  33. Crystal structure of 8,8′-di-p-tolyl-8′H-7,8′-biacenaphtho[1,2-d]imidazole, C40H26N4
  34. The crystal structure of 3-amino-(2,4-dioxopent-3-yl)-4,5-dihydro-1,2,4-triazinium nitrate, C8H13N5O5
  35. Crystal structure of 4,4′,5,5′-tetraphenyl-2,2′-di-p-tolyl-2′H-1,2′-biimidazole, C44H34N4
  36. Halogen bonds in the crystal structure of 2-bromo-1,10-phenanthroline – 1,4-diiodotetrafluorobenzene (2/1), C30H14Br2F4I2N4
  37. Crystal structure of tris(1-phenyl-1,2-propanedione-2-oximato-κ2N,O)cobalt(III), C27H24N3O6Co
  38. Crystal structure of chlorido-(6,6′-((1,2-phenylenebis(azanylylidene))bis(methanylylidene))bis(3-methoxyphenolato)-κ4O,N,N′,O′)iron(III), C22H18ClN2FeO4
  39. Crystal structure of bis(μ2-1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-olato-κ3O,O′:O′)-bis-(1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-olato-κ2O,O)-bis(ethyl acetate-κO)dicadmium(II), C88H64Cl4N8O12S4Cd2
  40. Crystal structure of catena-poly[dichlorido-(μ2-3-(2-pyridyl)-4-(4-pyridyl)-5-(3-pyridyl)-1,2,4-triazole-κ2N:N′)] copper(II), C17H12N6Cl2Cu
  41. Crystal structure of dichlorido-([2,2′:6′,2′′-terpyridine]-4′-carboxylic acid-κ3N,N′,N′′)copper(II) monohydrate, C16H13Cl2CuN3O3
  42. Crystal structure of triethylammonium(5-carboxypyridine-2-thiolato-κ2N,S)-bis(dimethylsulfoxide-κ1S)-(6-sulfidonicotinato-κ2N,S)ruthenium(II) trihydrate, C22H41N3O9RuS4
  43. The crystal structure of poly[(μ5-2,5-dicarboxy-benzoato-κ4O:O:O′:O′′,O′′′)silver(I)], C9H5AgO6
  44. Crystal structure of (E)-1-(thiophen-2-yl)-N-(5-((triphenylstannyl)thio)-1,3,4-thiadiazol-2-yl)methanimine, C25H19N3S3Sn
  45. Crystal structure of diaqua-bis(3,5-dichloroisonicotinato-κ1O)-bis(1,3-di(pyridin-4-yl)propane-κ1N)cobalt(II), C38H36Cl4N6O6Co
  46. Crystal structure of dodecaaqua-bis(μ2-4,4′-bipyridine-κ2N:N′)-bis(4,4′-((5-carboxylato-1,3-phenylene)bis(oxy))dibenzoato-κ1O)tricopper(II) - water (1/4), C62H70Cu3N4O32
  47. Crystal structure of bis(5-methoxy-2-(((2-oxidoethyl)imino)methyl)phenolate-κ3O,N,O′)manganes(IV), C20H22N2O6Mn
  48. Crystal structure of tetramethylammonium (2-(3-ethoxy-2-oxidobenzylidene)-1-(2-hydroxybenzoyl)hydrazin-1-ido-κ3N,N′,O)cobalt(III), C36H40N5O8Co
  49. Crystal structure of 6-cyclohexyl-6,7-dihydrodibenzo[c,f][1,5]azabismocin-12(5H)-yl nitrate, C20H23O3N2Bi
  50. Crystal structure of (E)-N-((2S,3S,4R,10R,13S, 17S)-17-(1-(dimethylamino) ethyl)-2,4-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)-2-methylbut-2-enamide, C24H48N2O3
  51. Crystal structure of (E)-2-((4-chlorophenyl)(phenyl)methylene)hydrazine-1-carbothioamide, C14H12ClN3S
  52. Crystal structure of 1-benzyl-3-cyano-6-phenyl-1,2-dihydropyridine, C19H16N2
  53. Isolation and crystal structure of 4-((2-(methoxycarbonyl)phenyl)amino)-2-methyl-4-oxobutanoic acid from Delphinium Grandiflorum, C13H15N1O5
  54. Crystal structure of tetraqua-bis(4-(hydroxymethyl)benzoato-κO)nickel(II), C16H22O10Ni
  55. Crystal structure of ajacisine D monohydrate, C30H44N2O9
  56. The crystal structure of (E)-4-(1-(2-aminophenylimino)ethyl)benzene-1,3-diol, C14H14N2O2
  57. Crystal structure of poly[(μ4-(4H-1,2,4-triazol-4-yl)phenyl)acetato-κ4N,N′,O,O′)(formiato-κ1O)cobalt(II)], C11H9CoN3O4
  58. The crystal structure of bis tetrabutylammonium bis(μ3-2,2,2-tri(hydroxymethyl)ethyl-4-((3-methoxy-3-oxopropyl)amino)-4-oxobutanoato)-(μ6-oxido)-hexakis(μ2-oxido)-hexaoxido-hexavanadium(V), C58H112N4O29V6
  59. Crystal structure of (N-benzylpropane-1,3-diamine-κ2N, N′)(2,2′-bipyridine-κ2N,N′)platinum(II) chloride, C20H24Cl2N4Pt
  60. Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-2-amine, C23H16ClN5O
  61. Crystal structure of poly-[(μ2(carboxylatomethyl)((3-nitrophenyl)sulfonyl)amido-κ3N: O:O′)(μ2-4,4′-bipyridine-κ2N:N′)copper(II)], C18H14CuN4O6S
  62. Crystal structure of poly-[(μ2-(carboxylatomethyl)((3-nitrophenyl)sulfonyl)amido-κ3N:O:O′)(μ2-4,4′-bipyridine-κ2N:N′) nickel(II)], C18H14NiN4O6S
  63. Crystal structure of N-((3R,10S,13S,17S)-17-((S)-1-(dimethylamino)ethyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)-N-methylbenzamide, C31H48N2O
  64. The crystal structure of dichloroido(1,3-bis(2,6-dimethyl-phenyl)-1H-3l4-imidazol-2-yl)(2-methyl-4,5-dihydrooxazol-κN)palladium(IV)-water (1/1), C23H29Cl2N3O2Pd
  65. Crystal structure of catena-poly[dibromido-{μ2-1,5-dimethyl-2-phenyl-4-((pyridin-4-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O}zinc(II)], C34H32Br4N8O2Zn2
  66. Crystal structure of diaqua-dichlorido-bis(μ2-2-(((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato-κ4O:O,N,O′)dicobalt(II), C36H36Cl2N6O6Co2
  67. Crystal structure of catena-poly[diaqua-(μ2-1,2-bis(4-pyridinyl)ethyane-κ2N:N′)-(μ2–pyridazine-4,5-dicarboxylato-κ2O:O′)]dizinc(II) dihydrate, C12H12ZnN3O6
  68. The crystal structure of 2-(4-chloro-2,6-dinitrophenyl)-1-(4-chloro)diazene oxide, C12H6Cl2N4O5
  69. Crystal structure of 2-isopropylthioxanthone, C16H14OS
  70. Crystal structure of methyl 2-(4-(3-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C19H17N5O2
  71. Crystal structure of 4,4-dimethyl-2-(trifluoromethyl)-4,5-dihydro-1H-imidazole, C6H9F3N2
  72. Crystal structure of N-methylanilinium 5,7-dihydroxy-4-oxo-2-phenyl-4H-chromene-8-sulfonate monohydrate, C22H21NO8S
  73. Crystal structure of methyl 4-acetoxybenzoate, C10H10O4
  74. Crystal structure of catena-poly[(bis(μ-1,1′-[(5-methoxy-2,4,6-trimethyl-1,3-phenylene)bis(methylene)]bis(1H-1,2,4-triazole)-κ2N:N′)-bis(isothiocyanato-κN)manganese(II)], C34H40MnN14O2S2
  75. Crystal structure of N-(2-methylphenyl)(propan-2-yloxy)carbothioamide, C11H15NOS
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0045/html
Button zum nach oben scrollen